Claims that the lifetime cost of medicare per acquired immune deficiency syndrome (AIDS) patient will not exceed $80,000, an amount similar to the cost of treating other serious illnesses. Argues that the total projected costs for treating AIDS patients between 1981 and 1991 will not exceed $22 billion. (TW)

Discusses a number of obstacles that limit effective education for reducing the incidence of acquired immune deficiency syndrome (AIDS) in the United States. Includes behaviors that must be changed, disagreement about the propriety of educational messages to prevent AIDS, and uncertainty as to some of the dual messages of reassurance being…